Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/27/2/294/6676047/mdv546.pdf
Reference25 articles.
1. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results;Rodel;J Clin Oncol,2002
2. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000
3. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 Guidelines;Witjes;Eur Urol,2014
4. Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer;Choudhury;J Clin Oncol,2011
5. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer;James;N Engl J Med,2012
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GAS6-AS1 drives bladder cancer progression by increasing MMP7 expression in a ceRNA- and RBP-dependent manner;Translational Oncology;2024-10
2. LOW-ENERGY VERTEBRAL COMPRESSION FRACTURES: DIFFERENTIAL DIAGNOSIS BETWEEN OSTEOPOROTIC AND MALIGNANT FRACTURES BY INFLAMMATORY BIOMARKERS;Journal of Turkish Spinal Surgery;2024-02-06
3. THE EFFECT OF IMMUNOLOGICAL BIOMARKERS - NLR, PLR, LMR, PD-L1 ON THE SURVIVAL OF PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER;Themed collection of papers from Foreign International Scientific Conference «Modern research on the way to a new scientific revolution». Part 2. by HNRI «National development» in cooperation with AFP (Puerto Cabezas, Nicaragua). November 2023. – Varadero (Cuba);2024-01-23
4. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients;Frontiers in Immunology;2024-01-11
5. Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy;Anticancer Research;2023-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3